mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.003 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.004 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.005 |